All Type of News
JW Life Science acquires EU GMP for nutritional fluids for first time as Asian pharma
JW acquired approval for EU-GMP of its nutritional fluid products for the first time as an Asian pharmaceutical company.
JW Life Science(CEO Sung-Nam Cha), a subsidiary of JW Holdings, announced on the 3rd that the c...
Pharma distribution industry facing limitation with 3-shipments-a-day system
“It is impossible to make 3 shipments a day in the current circumstance. The key is, however, who will become the first one to be against the pharmacies’ opposition.”
The pharmaceutical distribution industry is repor...
Employees working for listed pharmas making KRW 54.7 million a year on average
The average yearly salary for employees working in listed pharmaceutical companies reportedly was KRW 54.7 million, and employees at Yuhan Corporation and Ildong Pharmaceutical were earning more than KRW 70 million.
...
Samsung Biologics, Arlico, Celltrion, Medytox and CMG in sales increase in order
KOSPI listed pharmaceutical companies recorded an average sales increase rate 1% higher than the one KOSDAQ listed pharmaceutical companies made last year.
Yakup Shinmoon(www.yakup.com) analyzed sales that 39 KOSPI a...
Pharma industry, “It’s the most important time to eradicate illegal rebates and establish ethical management”
The pharmaceutical industry will harden its will for ethical management. Since Chair Jung-Hee Lee of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association particularly has a strong will towards ethical man...
AbbVie Korea have regular appointment of personnel, such as Vice President So-Young Kang
AbbVie Korea(CEO Hong-Ki Yoo), a global biopharmaceutical company, announced the regular appointment as promoting Excusive Director So-Young Kang(48) to Vice President and Managing Director Ui-Han Lee(47) to Executive...
‘Dupilumab,’ moderate-to-severe eczema therapy, lands in Korea
‘Dupilumab,’ a moderate-to-severe eczema treatment for adults, will land in the Korean market.
As of 30 March, the Ministry of Food and Drug Safety(MFDS) approved Sanofi-Aventis Korea’s ‘Dupixent Prefilled Inj 300mg(...
Decreasing R&D/sales percentage with severe polarization among companies
The listed pharmaceutical companies’ percentage of R&D expenses to sales is decreasing while the polarization among companies in the category is getting severe.
Yakup Shinmoon(www.yakup.com) analyzed 2018 business re...
What figures listed pharmas had in regards to net profits?
While KOSPI listed pharmaceutical companies had an average net profit increase rate more than 150% last year, KOSDAQ listed pharmaceutical companies had a negative figure in the same index. KOSPI pharmaceutical compan...
Will pharmas start to make payments with credit card for pharma distribution companies?
Policies that the Korea Pharmaceutical Distribution Association(KPDA) is carrying out against pharmaceutical companies, such as credit card payment from pharmaceutical companies and recovery of low drug distribution c...
